Akili Inc
General ticker "AKLI" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $33.5M
Akili Inc does not follow the US Stock Market performance with the rate: -23.3%.
Estimated limits based on current volatility of 1.3%: low 0.43$, high 0.44$
Factors to consider:
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 predicted range: [0.29$, 1.54$]
- 2024-12-30 to 2025-12-30 predicted range: [0.64$, 2.63$]
Financial Metrics affecting the AKLI estimates:
- Negative: Non-GAAP EPS of -0.68 <= 0.09
- Negative: Operating Income to Revenue ratio of -0.97 <= 0.01
- Negative: negative Net Income
- Negative: Operating Cash Flow per share of -0.74 <= 0.21
Short-term AKLI quotes
Long-term AKLI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.54MM | $0.32MM | $1.68MM |
| Operating Expenses | $61.26MM | $91.00MM | $66.16MM |
| Operating Income | $-60.72MM | $-90.68MM | $-64.48MM |
| Non-Operating Income | $-0.63MM | $82.73MM | $4.99MM |
| Interest Expense | $0.47MM | $1.48MM | $2.36MM |
| R&D Expense | $18.23MM | $28.86MM | $19.93MM |
| Income(Loss) | $-61.35MM | $-7.95MM | $-59.49MM |
| Taxes | $0.00MM | $0.02MM | $0.00MM |
| Profit(Loss) | $-61.35MM | $-7.96MM | $-59.49MM |
| Stockholders Equity | $-226.11MM | $110.68MM | $58.53MM |
| Assets | $80.94MM | $144.56MM | $80.38MM |
| Operating Cash Flow | $-53.98MM | $-83.52MM | $-57.87MM |
| Investing Cash Flow | $-0.49MM | $-81.22MM | $83.41MM |
| Financing Cash Flow | $112.84MM | $141.94MM | $-4.49MM |
| Earnings Per Share* | $-1.94 | $-0.27 | $-0.76 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.